CD274 and neoplasm: There was some limitations of PD‐L1 as a biomarker because of its dynamic and heterogeneous expression in the tumor microenvironment, variable assay interpretation, and lack of standardization between platforms,30 tumor types.31, 32, 33, 34, 35